The Bronchiectasis and NTM Association announced today that an abstract using Bronchiectasis and NTM Research Registry data will be presented as a rapid-fire presentation at CHEST 2026, held October 18-21, 2026, in Phoenix.
The abstract, "Bronchiectasis in Sjögren's Syndrome: Data from the U.S. Bronchiectasis and NTM Research Registry," compared the demographic, clinical, and microbiologic characteristics of people with Sjögren's syndrome-associated bronchiectasis to people with bronchiectasis without Sjögren's syndrome.
The Registry, an initiative of the Bronchiectasis and NTM Association, is a national database that collects clinical data from individuals diagnosed with non-cystic fibrosis (non-CF) bronchiectasis and nontuberculous mycobacterial (NTM) pulmonary disease. It includes participants from multiple clinical institutions across the United States to help support collaborative research and planning of multi-center clinical trials.
The Bronchiectasis and NTM Association would like to acknowledge that the Registry is supported in part by corporate donors, all of which can be found on the Supporters page of the Association website.